Covestor LTD Xencor Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Xencor Inc stock. As of the latest transaction made, Covestor LTD holds 35 shares of XNCR stock, worth $793. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 4 775.0%

Holding current value

$793

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$15.7 - $21.65 $486 - $671	31 Added 775.0%	35 $1,000
Q2 2024 Aug 09, 2024	SELL	$18.21 - $24.5 $491 - $661	-27 Reduced 87.1%	4 $0
Q1 2024 May 10, 2024	BUY	$18.65 - $26.52 $242 - $344	13 Added 72.22%	31 $1,000
Q4 2023 Feb 09, 2024	BUY	$16.53 - $21.42 $66 - $85	4 Added 28.57%	18 $0
Q3 2023 Nov 13, 2023	SELL	$20.08 - $25.39 $20 - $25	-1 Reduced 6.67%	14 $0
Q2 2023 Aug 11, 2023	SELL	$24.77 - $29.9 $247 - $299	-10 Reduced 40.0%	15 $0
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $103 - $147	4 Added 19.05%	25 $1,000
Q4 2022 Feb 13, 2023	SELL	$24.79 - $30.86 $247 - $308	-10 Reduced 32.26%	21 $0
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $467 - $616	19 Added 158.33%	31 $1,000
Q2 2022 Aug 10, 2022	BUY	$19.74 - $29.01 $19 - $29	1 Added 9.09%	12 $0
Q1 2022 May 13, 2022	SELL	$26.68 - $41.63 $80 - $124	-3 Reduced 21.43%	11 $0
Q4 2021 Feb 10, 2022	BUY	$33.67 - $43.44 $471 - $608	14 New	14 $1,000

Others Institutions Holding XNCR

# of Institutions

200

Shares Held

63.2M

Call Options Held

3.9K

Put Options Held

Black Rock Inc. New York, NY

11.1M
Shares

$252 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

9.12M
Shares

$207 Million
0.13% of portfolio
Vanguard Group Inc Valley Forge, PA

7M
Shares

$159 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.33M
Shares

$121 Million
3.57% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.96M
Shares

$89.9 Million
0.01% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.35B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account